Salmonella-induced reactive arthritis in a chronic myeloid leukemia patient on hydroxyurea and interferon-alpha
Soppi, E.; Lahtinen, R.
Clinical and Experimental Rheumatology 6(4): 425-426
1988
ISSN/ISBN: 0392-856X PMID: 3229035 Document Number: 317601
Document emailed within 1 workday
Related Documents
Ladoyanni, E.; Nambi, R. 2005: Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia Journal of Drugs in Dermatology: Jdd 4(2): 221-222Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Faber, E.; Jarosová, M.; Divoký, V.; Luhový, M.; Komenda, S.; Sulovská, I.; Hubácek, J.; Slezák, P.; Papajik, T.; Raida, L.; Heczko, M.; Indrák, K. 1997: Interferon-alpha in the treatment of patients with chronic myeloid leukemia Vnitrni Lekarstvi 43(1): 13-17
Ezaki, K. 2000: Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 279-284
Zuffa, E.; Bandini, G.; Bonini, A.; Santucci, M.A.; Martinelli, G.; Rosti, G.; Testoni, N.; Zaccaria, A.; Tura, S. 1998: Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia Haematologica 83(3): 231-236
Molnár, L.; Nagy, A.; Dávid, M.; Szomor, A.ád.; Méhes, G.áb.; Kovács, G.áb.; Losonczy, H. 2004: Results of imatinib therapy in late-stage chronic myeloid leukemia after treatment with interferon-alpha Orvosi Hetilap 145(17): 901-907
Agarwal, M.B.; Mehta, B.C. 1982: Hydroxyurea therapy in chronic myeloid leukemia Journal of the Association of Physicians of India 30(7): 427-428
Casado, L.F.; Picó, M.; Gómez, C.; Ferro, M.T.; Fernández-Rañada, J.M.; Steegmann, J.L. 1997: Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete cytogenetic response after alpha interferon treatment Medicina Clinica 109(7): 251-255
Gronthos, S.; To, L.B.; Moore, S.; Suttle, J.M.; Juttner, C.A. 1992: The detection of Philadelphia chromosome negative metaphases in long-term bone marrow cultures of the peripheral blood from patients with chronic myeloid leukemia predicts response to interferon-alpha 2a Leukemia 6(12): 1246-1249
Morabito, F.; Callea, I.; Rodinò, A.; Messina, G.; Callea, V.; Iacopino, P.; Nobile, F.; Brugiatelli, M. 1995: Modulation of purine analogs- and chlorambucil-induced cytotoxicity by alpha-interferon and interleukin-2 in chronic lymphocytic leukemia Leukemia 9(9): 1450-1455
Lo Coco, F.; Mandelli, F.; Diverio, D.; Alimena, G.; De Fabritiis, P.; Meloni, G.; Cedrone, M.; Frontani, M.; Guerrasio, A.; Saglio, G. 1990: Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion Bone Marrow Transplantation 6(4): 253-258
Repo, H.; Koivuranta-Vaara, P.; Leirisalo-Repo, M.; Lauharanta, J.; Osterman, T.; Vapaatalo, H. 1987: Etretinate therapy and neutrophil function in a patient with reactive arthritis triggered by Salmonella infantis Clinical and Experimental Rheumatology 5(4): 388-390
Arana-Trejo, R.M.; Ovilla-Martínez, R.; Gómez-Morales, E.; Meillon-García, L.; Cervantes-Peredo, A.; González-Llaven, J.; Pizzuto-Chávez, J.; Kofman-Alfaro, S. 1997: Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 49(3): 209-214
Cervantes, F.; Hernández-Boluda, J-Carlos.; Steegmann, J-Luis.; Conde, E.; Alvarez-Larrán, A.; López-Jiménez, J.; Osorio, S.; Villalón, Lía.; Camós, M.; García-Conde, J.; Odriozola, Jús. 2003: Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients Haematologica 88(10): 1117-1122
Nakayama, S.; Ishikawa, T.; Yabe, H.; Nagai, K.; Kasakura, S.; Uchino, H. 1988: Successful treatment of a patient with acute myeloid leukemia with 1 alpha(OH)D3 Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 51(6): 1026-1030
Almasio, P.; Mirto, S.; Malleo, C.; Di Marco, V.; Caronia, F.; Craxi, A. 1991: Recombinant interferon alpha-2B for acute post-transfusion hepatitis in acute myeloid leukemia Haematologica 76(5): 429-430
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Shiozawa, S.; Chihara, K.; Shiozawa, K.; Fujita, T.; Ikegami, H.; Koyama, S.; Kurimoto, M. 1986: A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients Clinical and Experimental Immunology 66(1): 77-87
Klener, P.; Háber, J.; Hausner, P. 1989: Alpha-2b interferon in the treatment of advanced chronic lymphocytic leukemia Neoplasma 36(2): 215-220